Shinobi Therapeutics Teams Up with Panasonic to Develop Affordable and Efficient iPS Cell Therapy Manufacturing Technology

Shots:

Shinobi Therapeutics partners with Panasonic Holding Corps and Kyoto University’s Center for iPS Cell Research and Application (CiRA) to develop affordable and accessible Immune evasive iPS-T cell therapies for broader population
The partnership aims to leverage Panasonic’s manufacturing expertise to develop a new method to produce iPS-T cell therapies in a closed system process
With the completion of the first phase of the initial partnership in Apr’25, the companies will release their initial prototype

Ref: Shinobi Therapeutics | Image: Shinobi Therapeutics